AAAAAA

   
Results: 1-9 |
Results: 9
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer
Authors: Elisaf, MS Bairaktari, ET Nicolaides, C Kakaidi, B Tzallas, CS Katsaraki, A Pavlidis, NA
Citation: Ms. Elisaf et al., Effect of letrozole on the lipid profile in postmenopausal women with breast cancer, EUR J CANC, 37(12), 2001, pp. 1510-1513
The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia - A pilot study involving serial sampling
Authors: Goudevenos, JA Bairaktari, ET Chatzidimou, KG Milionis, HJ Mikhailidis, DP Elisaf, MS
Citation: Ja. Goudevenos et al., The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia - A pilot study involving serial sampling, CURR MED R, 16(4), 2001, pp. 269-275
Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia
Authors: Milionis, HJ Bairaktari, ET Liberopoulos, EN Elisaf, MS
Citation: Hj. Milionis et al., Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia, AM J CARD, 88(2), 2001, pp. 203-203
Lipoprotein (a), apolipoprotein (a) phenotypes, and thyroid autoimmunity in uremic patients
Authors: Bairaktari, ET Milionis, HJ Katopodis, K Tzallas, C Tselepis, AD Tsolas, O Siamopoulos, KC Elisaf, MS
Citation: Et. Bairaktari et al., Lipoprotein (a), apolipoprotein (a) phenotypes, and thyroid autoimmunity in uremic patients, ENDOCRINOLO, 10(6), 2000, pp. 383-388
Aminoglycoside-induced metabolic abnormalities
Authors: Liamis, G Alexandridis, G Bairaktari, ET Elisaf, MS
Citation: G. Liamis et al., Aminoglycoside-induced metabolic abnormalities, ANN CLIN BI, 37, 2000, pp. 543-544
Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia
Authors: Bairaktari, ET Tzallas, CS Tsimihodimos, VK Liberopoulos, EN Miltiadous, GA Elisaf, MS
Citation: Et. Bairaktari et al., Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia, J CARD RISK, 6(2), 1999, pp. 113-116
Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunity
Authors: Bairaktari, ET Tselepis, AD Millionis, HJ Elisaf, MS
Citation: Et. Bairaktari et al., Lipoprotein (a) levels, apolipoprotein (a) phenotypes and thyroid autoimmunity, EUR J ENDOC, 140(5), 1999, pp. 474-476
Effect of fenofibrate on serum uric acid levels
Authors: Liamis, G Bairaktari, ET Elisaf, MS
Citation: G. Liamis et al., Effect of fenofibrate on serum uric acid levels, AM J KIDNEY, 34(3), 1999, pp. 594-594
Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parameters
Authors: Bairaktari, ET Hatzidimou, K Elisaf, MS
Citation: Et. Bairaktari et al., Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parameters, EUR HEART J, 20(24), 1999, pp. 1844-1844
Risultati: 1-9 |